Showing results (1371-1380 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|April 29, 2015
Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trialFaiez Zannad, Barry Greenberg, John G F Cleland, et al.
European Journal of Heart Failure|August 26, 2025
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trialMarkus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
European Journal of Heart Failure|September 2, 2025
Low-dose digoxin improves cardiac function in patients with heart failure, preserved ejection fraction and atrial fibrillation - the RATE-AF randomized trialKarina V Bunting, Asgher Champsi, Simrat K Gill, et al.
European Journal of Heart Failure|April 9, 2020
The impact of residual mitral regurgitation after MitraClip therapy in functional mitral regurgitationDaniel Reichart, Daniel Kalbacher, Nicole Rübsamen, et al.
European Journal of Heart Failure|May 16, 2020
COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new diseaseDaniela Tomasoni, Leonardo Italia, Marianna Adamo, et al.
European Journal of Heart Failure|July 19, 2016
Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programmeKevin Damman, Scott D Solomon, Marc A Pfeffer, et al.
European Journal of Heart Failure|July 18, 2015
Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA)Oliver P Guttmann, Menelaos Pavlou, Constantinos O'Mahony, et al.
European Journal of Heart Failure|July 4, 2015
Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) studyMark T Ledwidge, Eoin O'Connell, Joseph Gallagher, et al.
European Journal of Heart Failure|May 27, 2015
Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trialMichael R MacDonald, Lilin She, Torsten Doenst, et al.
European Journal of Heart Failure|May 27, 2015
Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapyMichael R Zile, William T Abraham, Fred A Weaver, et al.
Pageof 398